Evidence map›Paper›PMID 41625888›Full record

ArticleCureus2025

A Histological Conundrum With a Distinctive Biochemical Marker: A Case Report of Primary Pulmonary Choriocarcinoma.

Timothy Ming Him Yeung, Raymond Yu O, Karen Ka-Wan Yuen, Sidney Tam

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Repurposing metformin for choriocarcinoma: targeting the AMPK/mTOR pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timothy Ming Him YeungDivision of Chemical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong, HKG.
Raymond Yu ODepartment of Pathology, The University of Hong Kong, Hong Kong, HKG.
Karen Ka-Wan YuenDivision of Anatomical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong, HKG.
Sidney TamDivision of Chemical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong, HKG.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary pulmonary choriocarcinoma (PPC) is a rare, malignant germ cell neoplasm with a poor prognosis that is difficult to diagnose. Measurement of human chorionic gonadotropin (hCG), which is secreted by PPCs, facilitates the detection of PPCs. We describe a 69-year-old man who presented with shortness of breath and was found to have a large lung tumor. Histological examination of the biopsied right lung mass revealed tumor cells with enlarged pleomorphic nuclei, irregular nuclear contour, and conspicuous nucleoli. Immunostaining of the tumor cells was positive for MNF-116 and patchily positive for p40, while negative for leukocyte common antigen (LCA (CD45)), S100, smooth muscle actin (SMA), thyroid transcription factor 1 (TTF-1), and synaptophysin. While such features mimicked squamous cell carcinoma, an extremely elevated serum total hCG level of 24544 IU/L prompted further immunohistochemical staining for choriocarcinomas. The tumor was positive for spalt-like transcription factor 4 (SALL4) and GATA-binding protein 3 (GATA3), which established the diagnosis of PPC. This case illustrates the histopathological difficulties in diagnosing PPC and the utility of serum hCG measurement in the detection of PPC. Serum hCG measurement is useful as an initial investigation for possible PPC in patients with non-small cell lung tumors, which should be followed by immunohistochemical staining for markers of choriocarcinoma.

Indexed as

gata3hcgimmunohistochemistry (ihc)primary choriocarcinomaprimary pulmonary choriocarcinomasall4squamous cell carcinoma (scc)

Identifiers

PMID41625888
PMCPMC12852959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.